2023 | 2022 | ||||||
Pre- | 2023 | Pre- | 2022 | ||||
exceptional | Exceptional | 2023 | exceptional | Exceptional | 2022 | ||
items | items (note 4) | Total | items | items (note 4) | Total | ||
£m | £m | £m | £m | £m | £m | ||
Revenue | 3 | ||||||
Cost of sales | ( | ( | ( | ( | ( | ( | |
Gross profit/(loss) | ( | ( | |||||
Net administrative expenses | 5 | ( | ( | ( | ( | ||
Net impairment losses on financial | |||||||
assets | 17 | ( | ( | ( | ( | ||
Operating profit/(loss) | 5 | ( | ( | ||||
Finance income | 7 | ||||||
Finance expense | 7 | ( | ( | ( | ( | ( | ( |
Net finance expense | ( | ( | ( | ( | ( | ( | |
Share of post-tax profits/(losses) | |||||||
of joint ventures using the equity | |||||||
method | 14 | ( | |||||
Profit/(loss) before tax | ( | ( | |||||
Income tax (expense)/credit | 8 | ( | ( | ( | ( | ||
Profit/(loss) for the year | |||||||
attributable to equity | |||||||
shareholders | ( | ( | |||||
Earnings per ordinary share | |||||||
Basic | 10 | ||||||
Diluted | 10 |
2023 | 2022 | ||
£m | £m | ||
Profit for the year attributable to equity shareholders | |||
Other comprehensive (expense)/income: | |||
Items that will not be reclassified to the consolidated income statement: | |||
Actuarial losses of defined benefit schemes | 16 | ( | ( |
Change in deferred tax on actuarial losses of defined benefit schemes | 15 | ||
Other comprehensive expense for the year net of income tax | ( | ( | |
Total comprehensive income attributable to equity shareholders |
Share premium | Retained | ||||
Share capital | account | earnings | Total equit y | ||
£m | £m | £m | £m | ||
Balance at 1 November 2021 | |||||
Profit for the year attributable to equity shareholders | |||||
Actuarial losses of defined benefit schemes | 16 | ( | ( | ||
Change in deferred tax on actuarial losses of defined benefit | |||||
schemes | 15 | ||||
Total comprehensive income for the year | |||||
Transactions with shareholders: | |||||
Equity-settled share-based payments | 16 | ||||
Deferred tax on equity-settled share-based payments | 15 | ( | ( | ||
Purchase of own shares | 23 | ( | ( | ||
Dividends paid | 9 | ( | ( | ||
Balance at 31 October 2022 | |||||
Profit for the year attributable to equity shareholders | |||||
Actuarial losses of defined benefit schemes | 16 | ( | ( | ||
Change in deferred tax on actuarial losses of defined benefit | |||||
schemes | 15 | ||||
Total comprehensive income for the year | |||||
Transactions with shareholders: | |||||
Equity-settled share-based payments | 16 | ||||
Deferred tax on equity-settled share-based payments | 15 | ( | ( | ||
Purchase of own shares | 23 | ( | ( | ||
Transfers in respect of share options | |||||
Dividends paid | 9 | ( | ( | ||
Balance at 31 October 2023 |
2023 | 2022 | ||
£m | £m | ||
Non-current assets | |||
Intangible assets | 11 | ||
Property, plant and equipment | 12 | ||
Right-of-use assets | 13 | ||
Investments in joint ventures | 14 | ||
Financial assets at fair value through profit and loss | |||
Deferred tax assets | 15 | ||
Retirement benefit surplus | 16 | ||
Trade and other receivables | 17 | ||
Current assets | |||
Inventories | 18 | ||
Financial assets at fair value through profit and loss | |||
Trade and other receivables | 17 | ||
Current income tax receivable | |||
Cash and cash equivalents | 19 | ||
Total assets | |||
Liabilities | |||
Non-current liabilities | |||
Interest-bearing loans and borrowings | 20 | ( | ( |
Trade and other payables | 21 | ( | ( |
Lease liabilities | 13 | ( | ( |
Deferred tax liabilities | 15 | ( | ( |
Provisions | 22 | ( | ( |
( | ( | ||
Current liabilities | |||
Interest-bearing loans and borrowings | 20 | ( | |
Trade and other payables | 21 | ( | ( |
Lease liabilities | 13 | ( | ( |
Provisions | 22 | ( | ( |
( | ( | ||
Total liabilities | ( | ( | |
Net assets | ( | ( | |
Equity | |||
Share capital | 23 | ||
Share premium account | 23 | ||
Retained earnings | |||
Total equity |
2023 | 2022 | ||
£m | £m | ||
Cash flows from operating activities | |||
Profit for the year attributable to equity shareholders | |||
Adjustments for: | |||
Depreciation on property, plant and equipment | 12 | ||
Depreciation on right-of-use assets | 13 | ||
Retirement benefit obligation administrative expenses | 16 | ||
Net finance expense | 7 | ||
Share-based payment expense | 16 | ||
Share of post-tax profits of joint ventures using the equity method | 14 | ( | ( |
Impairment of inventories movement | 18 | ( | |
Net impairment of financial assets | 17 | ||
Income tax expense | 8 | ||
Operating profit before changes in working capital, provisions and contributions to retirement benefit obligations | |||
Decrease/(increase) in trade and other receivables | ( | ||
(Increase)/decrease in inventories | ( | ||
Decrease in trade and other payables and provisions | ( | ( | |
Contribution to retirement benefit obligations | 16 | ( | ( |
Cash (used by)/generated from operations | ( | ||
Finance expense paid | ( | ( | |
Income tax paid | ( | ( | |
Net cash (outflow)/inflow from operating activities | ( | ||
Cash flows from investing activities | |||
Purchases of property, plant and equipment | 12 | ( | ( |
Disposal of financial assets at fair value through profit and loss | |||
Funding to joint ventures | ( | ( | |
Repayment of funding from joint ventures | |||
Dividends received from joint ventures | |||
Finance income received | |||
Net cash inflow from investing activities | |||
Cash flows from financing activities | |||
Principal elements of lease payments | 13 | ( | ( |
Dividends paid | 9 | ( | ( |
Net purchase of own shares | ( | ( | |
Debt arrangement and facility fees | ( | ||
Net cash outflow from financing activities | ( | ( | |
Net (decrease)/increase in cash and cash equivalents | ( | ||
Cash and cash equivalents at the beginning of the year | |||
Cash and cash equivalents at the end of the year | 19 |
2023 | 2022 | |
£m | £m | |
Open market housing including specification upgrades | 550.0 | 803.7 |
88.0 | 76.9 | |
Total housing | 638.0 | 880.6 |
Land and commercial sales | 19.5 | 32.0 |
Freehold reversions | – | 1.0 |
Total revenue | 657.5 | 913.6 |
2023 | 2022 | |
£m | £m | |
Timing of revenue recognition | ||
Revenue recognised at a point in time | 552.4 | 842.6 |
Revenue recognised over time | 105.1 | 71.0 |
Total revenue | 657.5 | 913.6 |
2023 | 2022 | |
£m | £m | |
Assets and liabilities related to contracts with customers | ||
Contract assets (note 17) | 6.9 | 25.1 |
Contract liabilities (note 21) | (6.0) | (19.3) |
2023 | 2022 | |
£m | £m | |
Cost of sales | ||
Combustible materials charge | (11.3) | (102.5) |
Combustible materials credit | 10.0 | – |
Net combustible materials charge | (1.3) | (102.5) |
Legal provision | (13.0) | – |
Total cost of sales charge | (14.3) | (102.5) |
Net finance expense | ||
Combustible materials imputed interest | (4.6) | (1.0) |
Share of post-tax profit/(loss) of joint ventures | ||
Combustible materials credit/(charge) of joint ventures | 0.6 | (1.5) |
Total exceptional charge | (18.3) | (105.0) |
Tax credit on exceptional charge | 4.8 | 22.4 |
Total exceptional charge after tax credit | (13.5) | (82.6) |
2023 | 2022 | ||
£m | £m | ||
Inventories expensed in the year | (520.2) | (705.3) | |
Inventories impairment movement in the year | 18 | (7.6) | 8.1 |
Employee costs | 6 | (60.7) | (58.4) |
Depreciation on property, plant and equipment | 12 | (0.5) | (0.4) |
Depreciation on right-of-use assets | 13 | (2.3) | (1.9) |
Joint venture project management fees recognised in administrative expenses | 27 | 1.9 | 2.0 |
Net administrative expenses | £m | £m | |
Administrative expenses | (55.0) | (51.1) | |
Other operating income | 40.1 | 48.9 | |
Other operating expenses | (40.9) | (47.4) | |
Net administrative expenses | (55.8) |
2023 | 2022 | |
£000 | £000 | |
Auditors’ remuneration | ||
Audit of these consolidated financial statements | 166 | 137 |
Audit of financial statements of subsidiaries pursuant to legislation | 819 | 783 |
Other non-audit services | 154 | 95 |
2023 | 2022 | |
Number | Number | |
Development | 778 | 727 |
2023 | 2022 | |
£m | £m | |
Wages and salaries | 50.4 | 48.0 |
Social security costs | 5.8 | 6.0 |
Other pension costs | 3.0 | 2.5 |
Share-based payments (note 16) | 1.5 | 1.9 |
60.7 | 58.4 |
2023 | 2022 | |
£m | £m | |
Salaries and short-term employee benefits | 3.5 | 4.0 |
Directors’ remuneration for loss of | – | 0.5 |
Share-based payments | 0.6 | 1.0 |
4.1 | 5.5 |
2023 | 2022 | |
£m | £m | |
Salaries and short-term employee benefits | 1.7 | 2.6 |
Directors’ remuneration for loss of | – | 0.5 |
Share-based payments | 0.5 | 0.7 |
2.2 | 3.8 |
2023 | 2022 | |
£m | £m | |
Finance income | ||
Interest income | 2.4 | 0.7 |
Interest on amounts due from joint ventures (note 27) | 1.2 | 2.1 |
Net interest on defined benefit pension scheme (note 16) | 0.5 | 0.3 |
4.1 | 3 .1 | |
Finance expense | ||
Interest on bank loans | (5.7) | (6.6) |
Revolving credit facility issue costs | (0.6) | (0.7) |
Imputed interest on deferred land payables | (3.1) | (2.8) |
Interest on lease liabilities (note 13) | (0.2) | (0.1) |
Imputed interest on combustible materials provision – exceptional (note 22) | (4.6) | (1.0) |
(14.2) | (11.2) | |
Net finance expense | (10.1) | (8.1) |
2023 | 2022 | |
£m | £m | |
Current tax | ||
UK corporation tax expense on profit for the year | (4.2) | (6.1) |
Adjustment in respect of prior periods | 0.7 | – |
Total current tax expense | (3.5) | (6.1) |
Deferred tax | ||
Origination and rev | (1.7) | (0.3) |
Total deferred tax charge (note 15) | (1.7) | (0.3) |
Total income tax expense in consolidated income statement | (5.2) | (6.4) |
2023 | 2022 | |
£m | £m | |
Reconciliation of tax expense in the year | ||
Profit before tax | 23.1 | 32.8 |
Tax charge on profit at 26.5% (2022: 21.3%) | (6.1) | (7.0) |
Expenses not deductible for tax purposes | (0.8) | (0.7) |
Enhanced tax deductions | 0.3 | 0.2 |
Adjustment in respect of prior periods | 0.7 | – |
– | 0.6 | |
Impact of RPDT annual allowance and adjustments | 0.7 | 0.5 |
Total income tax expense in consolidated income statement | (5.2) | (6.4) |
2023 | 2022 | |
£m | £m | |
Dividends recognised as distributions to equity shareholders in the year: | ||
Current year interim dividend of | 14.1 | 14.1 |
Prior year final dividend per share of 11.5 pence per share (2022: 9.5 pence per share) | 29.5 | 24.4 |
43.6 | 38.5 |
2023 | 2022 | |
£m | £m | |
Dividends proposed as distributions to equity shareholders in the year: | ||
Final dividend for the year ended 31 October 2023 of | 29.5 | 29.5 |
Weighted | |||
average | |||
number of | Per share | ||
Earnings | ordinary shares | amount | |
£m | Number | Pence | |
Year ended 31 October 2023 | |||
Basic earnings per share | 17.9 | 256,131,621 | 7.0 |
Dilut | – | 594,762 | |
Diluted earnings per share | 17.9 | 256,726,383 | 7.0 |
Year ended 31 October 2023 – Pre-exceptional items | |||
Adjusted basic earnings per share | 31.4 | 256,131,621 | 12.3 |
Dilut | – | 594,762 | |
Adjusted diluted earnings per share | 31.4 | 256,726,383 | 12.2 |
Year ended 31 October 2022 | |||
Basic earnings per share | 26.4 | 256,405,006 | 10.3 |
Dilut | – | 1,320,375 | |
Diluted earnings per share | 26.4 | 257,725,381 | 10.2 |
Year ended 31 October 2022 – Pre-exceptional items | |||
Adjusted basic earnings per share | 109.0 | 256,405,006 | 42.5 |
Dilut | – | 1,320,375 | |
Adjusted diluted earnings per share | 109.0 | 257,725,381 | 42.3 |
2023 | 2022 | |
£m | £m | |
Cost at beginning and end of the year | 47.7 | 47.7 |
Accumulated impairment | (18.7) | (18.7) |
At beginning and end of the year | 29.0 | 29.0 |
Computer | |||
Fixtures and | equipment and | ||
fittings | software | Total | |
£m | £m | £m | |
Cost | |||
At 1 November 2021 | 1.8 | 3.2 | 5.0 |
Additions | – | 0.1 | 0.1 |
Disposals | (0.1) | (0.4) | (0.5) |
At 31 October 2022 | 1.7 | 2.9 | 4.6 |
Additions | 1.8 | – | 1.8 |
Disposals | – | (0.7) | (0.7) |
At 31 October 2023 | 3.5 | 2.2 | 5.7 |
Accumulated depreciation | |||
At 1 November 2021 | 1.0 | 2.8 | 3.8 |
Charge for the year | 0.2 | 0.2 | 0.4 |
Disposals | (0.1) | (0.4) | (0.5) |
At 31 October 2022 | 1.1 | 2.6 | 3.7 |
Charge for the year | 0.3 | 0.2 | 0.5 |
Disposals | – | (0.7) | (0.7) |
At 31 October 2023 | 1.4 | 2.1 | 3.5 |
Net book value | |||
At 31 October 2023 | 2.1 | 0.1 | 2.2 |
At 31 October 2022 | 0.6 | 0.3 | 0.9 |
At 1 November 2021 | 0.8 | 0.4 | 1.2 |
Motor vehicles | Total | ||
£m | £m | £m | |
Cost | |||
At 1 November 2021 | 13.1 | 4.2 | 17.3 |
Additions | – | 1.3 | 1.3 |
Disposals | – | (1.0) | (1.0) |
At 31 October 2022 | 13.1 | 4.5 | 17.6 |
Additions | 2.8 | 1.9 | 4.7 |
Disposals | (7.3) | (1.6) | (8.9) |
At 31 October 2023 | 8.6 | 4.8 | 13.4 |
Accumulated depreciation | |||
At 1 November 2021 | 10.7 | 2.9 | 13.6 |
Charge for the year | 1.0 | 0.9 | 1.9 |
Disposals | – | (1.0) | (1.0) |
Reclassification | (0.6) | – | (0.6) |
At 31 October 2022 | 11.1 | 2.8 | 13.9 |
Charge for the year | 1.3 | 1.0 | 2.3 |
Disposals | (7.3) | (1.6) | (8.9) |
At 31 October 2023 | 5.1 | 2.2 | 7. 3 |
Net book value | |||
At 31 October 2023 | 3.5 | 2.6 | 6.1 |
At 31 October 2022 | 2.0 | 1.7 | 3.7 |
At 1 November 2021 | 2.4 | 1.3 | 3.7 |
2023 | 2022 | |
£m | £m | |
Lease liabilities included in the consolidated statement of financial position | ||
Non-current | 4.4 | 2.3 |
Current | 2.0 | 1.6 |
Total lease liabilities | 6.4 | 3.9 |
2023 | 2022 | |
£m | £m | |
Amounts recognised in the consolidated income statement | ||
Depreciation on right-of-use assets | 2.3 | 1.9 |
Interest on lease liabilities | 0.2 | 0.1 |
2023 | 2022 | |
£m | £m | |
Amounts recognised in the consolidated cash flow statement | ||
Principal element of lease payments | 2.4 | 2.1 |
2023 | 2022 | |
£m | £m | |
Maturity of undiscounted contracted lease cash flows | ||
Less than one year | 2.2 | 1.7 |
One to five years | 3.2 | 2.4 |
More than five years | 1.6 | – |
Total | 7.0 | 4 .1 |
2023 | 2022 | |
£m | £m | |
Total investments in joint ventures | ||
Crest A2D (Walton Court) LLP | 2.3 | 3.4 |
Elmsbrook (Crest A2D) LLP | 3.5 | 3.3 |
Crest Sovereign (Brooklands) LLP | 4.9 | 2.3 |
Crest Peabody (Turweston) LLP | – | – |
Other non-material joint ventures | – | – |
Total investments in joint ventures | 10.7 | 9.0 |
Crest | Crest | |||||
Crest A2D | Elmsbrook | Sovereign | Peabody | Other non- | ||
(Walton Court) | (Crest A2D) | (Brooklands) | (Turweston) | material joint | ||
LLP | LLP | LLP | LLP | ventures | Total | |
2023 | £m | £m | £m | £m | £m | £m |
Summarised statement of financial | ||||||
position | ||||||
Current assets | ||||||
Cash and cash equivalents | 0.2 | 6.0 | 0.4 | – | 0.2 | 6.8 |
Inventories | 64.8 | 4.6 | 16.7 | – | – | 86.1 |
Other current assets | 0.2 | 1.0 | 1.9 | 5.3 | 2.0 | 10.4 |
Current liabilities | ||||||
Financial liabilities | (52.0) | (1.4) | (1.1) | (0.3) | – | (54.8) |
Other current liabilities | (5.7) | (3.3) | (8.1) | (5.0) | (3.9) | (26.0) |
Non-current liabilities | ||||||
Financial liabilities | (3.0) | – | – | – | – | (3.0) |
Net assets/(liabilities) | 4.5 | 6.9 | 9.8 | – | (1.7) | 19.5 |
Reconciliation to carrying amounts | ||||||
Opening net assets/(liabilities) at 1 November 2022 | 6.7 | 6.5 | 4.6 | – | (2.9) | 14.9 |
(Loss)/profit for the year | (3.2) | 3.4 | 5.2 | – | 1.2 | 6.6 |
Capital contribution reserve | 1.0 | – | – | – | – | 1.0 |
Dividends paid | – | (3.0) | – | – | – | (3.0) |
Closing net assets/(liabilities) at 31 October 2023 | 4.5 | 6.9 | 9.8 | – | (1.7) | 19.5 |
Group’s share of closing net assets/(liabilities) at 31 October 2023 | 2.3 | 3.5 | 4.9 | – | (0.9) | 9.8 |
Fully provided in the Group financial statements | ||||||
(note 22) | – | – | – | – | 0.9 | 0.9 |
Group’s share in joint venture | 2.3 | 3.5 | 4.9 | – | – | 10.7 |
Amount due to the Group (note 17) | 27.4 | 1.4 | 0.4 | 0.3 | – | 29.5 |
Amount due from the Group (note 21) | – | – | – | – | 0.7 | 0.7 |
Summarised income statement | ||||||
Revenue | 0.9 | 21.1 | 47.2 | – | – | 69.2 |
Expenditure | (2.6) | (17.7) | (41.1) | – | – | (61.4) |
Expenditure – exceptional item (note 4) | – | – | – | – | 1.2 | 1.2 |
Operating (loss)/profit before finance expense | (1.7) | 3.4 | 6.1 | – | 1.2 | 9.0 |
Finance expense | (1.5) | – | (0.9) | – | – | (2.4) |
Pre-tax and post-tax (loss)/profit for the year | (3.2) | 3.4 | 5.2 | – | 1.2 | 6.6 |
Group’s share in joint venture (loss)/profit for the year | (1.6) | 1.7 | 2.6 | – | 0.6 | 3.3 |
Crest | ||||||
Crest A2D | Elmsbrook | Sovereign | Other non- | |||
Bonner Road | (Walton Court) | (Crest A2D) | (Brooklands) | material joint | ||
LLP 1 | LLP | LLP | LLP | ventures | Total | |
2022 | £m | £m | £m | £m | £m | £m |
Summarised statement of financial position | ||||||
Current assets | ||||||
Cash and cash equivalents | – | 0.1 | 1.6 | 0.3 | 0.2 | 2.2 |
Inventories | – | 40.4 | 7.8 | 28.8 | – | 77.0 |
Other current assets | – | 0.1 | 0.1 | 2.3 | 0.2 | 2.7 |
Current liabilities | ||||||
Financial liabilities | – | (0.6) | – | (1.0) | – | (1.6) |
Other current liabilities | – | (1.4) | (3.0) | (6.9) | (3.3) | (14.6) |
Non-current liabilities | ||||||
Financial liabilities | – | (31.9) | – | (18.9) | – | (50.8) |
Net assets/(liabilities) | – | 6.7 | 6.5 | 4.6 | (2.9) | 14.9 |
Reconciliation to carrying amounts | ||||||
Opening net (liabilities)/assets at 1 November 2021 | (13.7) | 4.3 | 8.9 | (1.0) | 0.2 | (1.3) |
(Loss)/profit for the year | (1.2) | 1.2 | 2.4 | 5.6 | (3.1) | 4.9 |
Capital contribution reserve | – | 1.2 | – | – | – | 1.2 |
Dividends paid | – | – | (4.8) | – | – | (4.8) |
Disposal in the year | 14.9* | – | – | – | – | 14.9 |
Closing net assets/(liabilities) at 31 October 2022 | – | 6.7 | 6.5 | 4.6 | (2.9) | 14.9 |
Group’s share of closing net assets/(liabilities) | ||||||
– | 3.4 | 3.3 | 2.3 | (1.4) | 7.6 | |
Losses recognised against receivable from joint | ||||||
venture (note 17) | – | – | – | – | 0.2 | 0.2 |
Fully provided in the Group financial statements | ||||||
(note 22) | – | – | – | – | 1.2 | 1.2 |
Group’s share in joint venture | – | 3.4 | 3.3 | 2.3 | – | 9.0 |
Amount due to the Group (note 17) | – | 15.9 | 0.8 | 10.4 | – | 27.1 |
Amount due from the Group (note 21) | – | – | – | – | 0.1 | 0.1 |
Summarised income statement for the 12months ending 31 October 2022 | ||||||
Revenue | – | 26.0 | 11.0 | 47.4 | – | 84.4 |
Expenditure | – | (23.6) | (8.6) | (39.9) | (0.1) | (72.2) |
Expenditure – exceptional item (note 4) | – | – | – | – | (3.0) | (3.0) |
Operating profit/(loss) before finance expense | – | 2.4 | 2.4 | 7.5 | (3.1) | 9.2 |
Finance expense | (1.2) | (1.2) | – | (1.9) | – | (4.3) |
Pre-tax and post-tax (loss)/profit for the year | (1.2) | 1.2 | 2.4 | 5.6 | (3.1) | 4.9 |
Group’s share in joint venture (loss)/profit | ||||||
(0.6) | 0.6 | 1.2 | 2.8 | (1.5) | 2.5 |
Other | ||||
Inventories | Share-based | temporary | ||
fair value | payments | Total | ||
Deferred tax assets | £m | £m | £m | £m |
At 1 November 2021 | 1.5 | 0.4 | 2.9 | 4.8 |
Consolidated income statement movements | – | 0.5 | (0.1) | 0.4 |
Equity movements | – | (0.4) | – | (0.4) |
At 31 October 2022 | 1.5 | 0.5 | 2.8 | 4.8 |
Consolidated income statement movements | (0.4) | (0.1) | (0.8) | (1.3) |
Equity movements | – | (0.2) | – | (0.2) |
At 31 October 2023 | 1.1 | 0.2 | 2.0 | 3.3 |
Pension | ||
surplus | Total | |
Deferred tax liabilities | £m | £m |
At 1 November 2021 | (4.1) | (4.1) |
Consolidated income statement movements | (0.7) | (0.7) |
Equity movements | 1.6 | 1.6 |
At 31 October 2022 | (3.2) | (3.2) |
Consolidated income statement movements | (0.4) | (0.4) |
Equity movements | 1.1 | 1.1 |
At 31 October 2023 | (2.5) | (2.5) |
2023 | 2022 | 2021 | |
£m | £m | £m | |
The amounts recognised in the consolidated statement of financial position | |||
are as follows: | |||
Fair value of scheme assets | 141.3 | 160.0 | 241.9 |
Present value of scheme liabilities | (131.3) | (148.9) | (225.2) |
Net surplus amount recognised at year end | 10.0 | 11.1 | 16.7 |
Deferred tax liability recognised at year end within non-current liabilities | (2.5) | (3.2) | (4.1) |
2023 | 2022 | |
£m | £m | |
Service cost | ||
Administrative expenses | (0.6) | (0.9) |
Interest income | 0.5 | 0.3 |
Recognised in the consolidated income statement | (0.1) | (0.6) |
2023 | 2022 | |
£m | £m | |
Remeasurements of the net liability | ||
Return on Scheme assets | (18.5) | (82.6) |
Gains arising from changes in financial assumptions | 12.5 | 79.8 |
Gains/(losses) arising from changes in demographic assumptions | 6.1 | (0.1) |
Experience losses | (2.6) | (5.5) |
Actuarial losses recorded in the consolidated statement of comprehensive income | (2.5) | (8.4) |
Total defined benefit scheme losses | (2.6) | (9.0) |
2023 | 2022 | |
% | % | |
The principal actuarial assumptions used were: | ||
Liability discount rate | 5.6 | 4.8 |
Inflation assumption – RPI | 3.3 | 3.2 |
Inflation assumption – CPI | 2.7 | 2.6 |
Revaluation of deferred pensions | 2.7 | 2.6 |
Increases for pensions in payment | ||
Benefits accrued in excess of GMP pre-1997 | 3.0 | 3.0 |
Benefits accrued post-1997 | 3.1 | 3.0 |
Proportion of employees opting for early retirement | 0.0 | 0.0 |
Proportion of employees commuting pension for cash | 100.0 | 100.0 |
Mortality assumption – pre-retirement | AC00 | AC00 |
Mortality assumption – male and female post-retirement | S3PA light base tables | |
(males and females) projected | S3PA light base tables | |
in line with CMI_2022 | projected in line with | |
core model with core | CMI_2021 | |
parameters (Sk = | core model with core | |
7.0, an initial addition of | parameters (Sk = | |
0.25%, w2020 | 7.0, an initial addition of | |
and w2021 set to zero | 0.25%, w2020 | |
and 2022 set to 25%) and | and w2021 set to zero) and | |
with a long-term rate of | with a long-term rate of | |
improvement of 1.25% p.a | improvement of 1.25% p.a |
2023 | 2022 | |
Years | Years | |
Future expected lifetime of current pensioner at age 65 | ||
Male aged 65 at year end | 22.9 | 23.4 |
Female aged 65 at year end | 24.6 | 25.0 |
Future expected lifetime of future pensioner at age 65 | ||
Male aged 45 at year end | 24.1 | 24.6 |
Female aged 45 at year end | 25.9 | 26.3 |
2023 | 2022 | |
£m | £m | |
Changes in the present value of assets over the year | ||
Fair value of assets at beginning of the year | 160.0 | 241.9 |
Interest income | 7.5 | 4.1 |
Return on assets (excluding amount included in net interest income) | (18.5) | (82.6) |
Contributions from the employer | 1.5 | 3.4 |
Benefits paid | (8.6) | (5.9) |
Administrative expenses | (0.6) | (0.9) |
Fair value of assets at end of the year | 141.3 | 160.0 |
Actual return on assets over the year | (10.9) | (78.5) |
2023 | 2022 | |
£m | £m | |
Changes in the present value of liabilities over the year | ||
Liabilities at beginning of the year | (148.9) | (225.2) |
Interest cost | (7.0) | (3.8) |
Remeasurement gains/(losses) | ||
Gains arising from changes in financial assumptions | 12.5 | 79.8 |
Gains/(losses) arising from changes in demographic assumptions | 6.1 | (0.1) |
Experience losses | (2.6) | (5.5) |
Benefits paid | 8.6 | 5.9 |
Liabilities at end of the year | (131.3) | (148.9) |
2023 | 2022 | |
£m | £m | |
Split of the Scheme’s liabilities by category of membership | ||
Deferred pensioners | (57.8) | (71.5) |
Pensions in payment | (73.5) | (77.4) |
(131.3) | (148.9) |
2023 | 2022 | |
Years | Years | |
Average duration of the Scheme’s liabilities at end of the year | 12.0 | 14.0 |
This can be subdivided as follows: | ||
Deferred pensioners | 16.0 | 18.0 |
Pensions in payment | 9.0 | 10.0 |
2023 | 2022 | |
£m | £m | |
Major categories of scheme assets | ||
Return seeking | ||
Overseas equities | 2.4 | 2.3 |
Other (hedge funds, multi asset strategy and absolute return funds) | 23.6 | 55.9 |
26.0 | 58.2 | |
Debt instruments | ||
Corporates | 11.8 | – |
Liability-driven investing | 44.1 | 71.6 |
55.9 | 71.6 | |
Other Cash | 55.9 | 25.9 |
Insured annuities | 3.5 | 4.3 |
59.4 | 30.2 | |
Total market value of assets | 141.3 | 160.0 |
26 Feb | 16 Apr | 21 Jun | 20 Feb | 04 Aug | 08 Feb | 28 Jan | 25 Aug | 06 Mar | 07 Aug | 27 Jan | |
Date of grant | 2016 | 2019 | 2019 | 2020 | 2020 | 2021 | 2022 | 2022 | 2023 | 2023 | 2023 |
Options | |||||||||||
granted | 1,075,943 | 1,140,962 | 278,558 | 1,125,531 | 7,298 | 1,328,192 | 1,341,918 | 23,955 | 29,462 | 508 | 1,771,417 |
Fair value at measurement | |||||||||||
date | £5.07 | £3.15 | £3.15 | £4.28 | £1.53 | £2.50 | £2.10 | £1.59 | £2.75 | £2.46 | £1.88 |
Share price | |||||||||||
on date of grant | £5.62 | £4.00 | £3.55 | £5.16 | £1.85 | £3.23 | £3.07 | £2.33 | £2.32 | £2.14 | £2.45 |
Exercise | |||||||||||
price | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
Vesting | |||||||||||
period | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years |
Expected | |||||||||||
dividend | |||||||||||
yield | 3.50% | 8.20% | 8.20% | 6.40% | 6.40% | 4.30% | 5.30% | 5.30% | N/A | N/A | 0.0% |
Expected | |||||||||||
volatility | 30.0% | 35.0% | 35.0% | 30.0% | 30.0% | 40.0% | 40.0% | 40.0% | N/A | N/A | 45.0% |
Risk-free | |||||||||||
interest rate | 0.43% | 0.81% | 0.81% | 0.45% | 0.45% | 0.03% | 0.97% | 0.97% | N/A | N/A | 3.23% |
Binomial/ | Binomial/ | Binomial/ | Binomial/ | ||||||||
Valuation | Monte | Monte | Monte | Monte | |||||||
model | Binomial | Binomial | Binomial | Binomial | Binomial | Carlo | Carlo | Carlo | N/A | N/A | Carlo |
Contractual | |||||||||||
life from Contractual | 26.02.16 | 16.04.19 | 21.06.19 | 20.02.20 | 04.08.20 | 08.02.21 | 28.01.22 | 25.08.22 | 06.03.23 | 07.08.23 | 27.01.23 |
life to | 25.02.26 | 15.04.29 | 20.06.29 | 19.02.30 | 03.08.30 | 07.02.31 | 27.02.32 | 27.02.32 | 19.02.30 | 03.08.30 | 26.01.33 |
Total | ||||||||||||
Movements | Number | Number | Number | Number | Number | Number | Number | Number | Number | Number | Number | Number |
in the year | of options | of options | of options | of options | of options | of options | of options | of options | of options | of options | of options | of options |
Outstanding | ||||||||||||
at 1 November | ||||||||||||
2021 | 1,518 | 692,934 | 278,558 | 954,131 | 7,298 | 1,276,437 | – | – | – | – | – | 3,210,876 |
Granted | ||||||||||||
during the year | – | – | – | – | – | – | 1,341,918 | 23,955 | – | – | – | 1,365,873 |
Exercised | ||||||||||||
during the year | (1,518) | – | – | – | – | – | – | – | – | – | – | (1,518) |
Lapsed | ||||||||||||
during the year | – | (692,934) | (278,558) | (62,161) | – | (78,761) | (29,443) | – | – | – | – | (1,141,857) |
Outstanding | ||||||||||||
at 31 | ||||||||||||
October | ||||||||||||
2022 | – | – | – | 891,970 | 7,298 | 1,197,676 | 1,312,475 | 23,955 | – | – | – | 3,433,374 |
Granted | ||||||||||||
during the year | – | – | – | – | – | – | – | – | 29,462 | 508 | 1,771,407 | 1,801,377 |
Exercised | ||||||||||||
during the year | – | – | – | (417,308) | (3,948) | – | – | – | (29,462) | (508) | – | (451,226) |
Lapsed | ||||||||||||
during the year | – | – | – | (474,662) | (3,350) | (167,438) | (181,150) | – | – | – | (201,028) | (1,027,628) |
Outstanding | ||||||||||||
at 31 | ||||||||||||
October | ||||||||||||
2023 | – | – | – | – | – | 1,030,238 | 1,131,325 | 23,955 | – | – | 1,570,379 | 3,755,897 |
Exercisable | ||||||||||||
at 31 | ||||||||||||
October | ||||||||||||
2023 | – | – | – | – | – | – | – | – | – | – | – | – |
Exercisable | ||||||||||||
at 31 October | ||||||||||||
2022 | – | – | – | – | – | – | – | – | – | – | – | – |
Total | ||||||||||||
£m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Charge to income for the current | ||||||||||||
year | – | – | – | 0.1 | – | – | 0.1 | – | 0.1 | – | 0.3 | 0.6 |
Charge to income for the prior year | – | – | – | 1.1 | – | (0.1) | 0.2 | – | – | – | – | 1.2 |
26 Jul | 30 Jul | 07 Aug | 03 Aug | 02 Aug | 28 Jul | |
Date of grant | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Options granted | 712,944 | 935,208 | 1,624,259 | 256,132 | 975,549 | 1,938,156 |
Fair value at measurement | ||||||
date | £0.52 | £0.54 | £0.36 | £1.15 | £0.66 | £1.51 |
Share price on date of grant | £3.77 | £3.68 | £1.94 | £4.14 | £2.67 | £2.19 |
Exercise price | £3.15 | £2.86 | £1.70 | £3.42 | £1.94 | £1.51 |
Vesting period | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years |
Expected | ||||||
dividend yield | 8.76% | 8.96% | 5.20% | 1.98% | 5.63% | 7.78% |
Expected | ||||||
volatility | 35.00% | 35.00% | 40.00% | 45.30% | 42.20% | 41.6% |
Risk-free interest | ||||||
rate | 0.85% | 0.38% | -0.08% | 0.14% | 1.62% | 4.63% |
Valuation model | Binomial | Binomial | Binomial | Binomial | Binomial | Binomial |
Contractual life | ||||||
from | 01.09.18 | 01.09.19 | 01.09.20 | 01.09.21 | 01.09.22 | 01.09.23 |
Contractual life to | 01.03.22 | 01.03.23 | 01.03.24 | 01.03.25 | 01.03.26 | 01.03.27 |
Total | Weighted | |||||||
Movements in the | Number of | Number of | Number of | Number of | Number of | Number of | number of | average |
year | options | options | options | options | options | options | options | exercise price |
Outstanding at 1 November 2021 | 40,842 | 147,357 | 1,124,088 | 244,294 | – | – | 1,556,581 | £2.12 |
Granted during the year | – | – | – | – | 975,549 | – | 975,549 | £1.94 |
Exercised during the year | (8,854) | – | (5,764) | – | – | – | (14,618) | £2.58 |
Lapsed during the year | (31,988) | (50,525) | (210,555) | (160,163) | (62,992) | – | (516,223) | £2.47 |
Outstanding at 31 October 2022 | – | 96,832 | 907,769 | 84,131 | 912,557 | – | 2,001,289 | £1.94 |
Granted during the year | – | – | – | – | – | 1,938,156 | 1,938,156 | £1.51 |
Exercised during the year | – | – | (522,976) | – | – | – | (522,976) | £1.70 |
Lapsed during the year | – | (96,832) | (61,983) | (41,201) | (486,485) | (158,774) | (845,275) | £2.02 |
Outstanding at 31 October 2023 | – | – | 322,810 | 42,930 | 426,072 | 1,779,382 | 2,571,194 | £1.64 |
Exercisable at 31 October 2023 | – | – | 322,810 | – | – | – | 322,810 | |
Exercisable at 31 October 2022 | – | 96,832 | – | – | – | – | 96,832 |
£m | £m | £m | £m | £m | £m | Total £m | |
Charge to | |||||||
income for the current year | – | – | 0.1 | – | 0.3 | 0.1 | 0.5 |
Charge to income | |||||||
for the prior year | – | – | 0.1 | 0.1 | 0.1 | – | 0.3 |
28 Feb | 26 Feb | 01 Mar | 28 Jan | 09 Feb | 06 Mar | 06 Mar | 27 Jan | |
Date of grant | 2020 | 2021 | 2022 | 2022 | 2022 | 2023 | 2023 | 2023 |
Options granted | 20,956 | 34,800 | 251 | 230,605 | 58,848 | 151 | 2,897 | 340,125 |
Fair value at measurement date | £4.52 | £3.28 | £4.06 | £2.76 | £2.76 | £2.75 | £2.53 | £2.44 |
Share price on date of grant | £4.52 | £3.28 | £2.70 | £3.06 | £3.27 | £2.32 | £2.32 | £2.45 |
Exercise price | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
Vesting period | 3 years | 1 year | N/A | 3 years | 1 year | N/A | N/A | 3/1 year |
Expected dividend yield | ||||||||
and volatility | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Risk-free interest rate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Valuation model | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Contractual life from | 28.02.20 | 26.02.21 | 02.03.22 | 28.01.22 | 09.02.22 | 06.03.23 | 06.03.23 | 27.01.23 |
Contractual life to | 27.02.30 | 25.02.31 | 25.02.31 | 27.01.25 | 08.02.23 | 27.02.30 | 08.02.32 | 28.02.33 |
Total | |||||||||
Number of | Number of | Number of | Number of | Number of | Number of | Number of | Number of | number of | |
Movements in the year | options | options | options | options | options | options | options | options | options |
Outstanding at | 2,260 | 34,800 | – | – | – | – | – | – | 37,060 |
Granted during the year | – | – | 251 | 230,605 | 58,848 | – | – | – | 289,704 |
Exercised during the year | – | (24,985) | (251) | – | – | – | – | – | (25,236) |
Lapsed during the year | – | (9,815) | – | – | – | – | – | – | (9,815) |
Outstanding at | 2,260 | – | – | 230,605 | 58,848 | – | – | – | 291,713 |
Granted during the year | – | – | – | – | – | 151 | 2,897 | 340,125 | 343,173 |
Exercised during the year | (2,260) | – | – | – | (48,374) | (151) | (2,897) | – | (53,682) |
Lapsed during the year | – | – | – | – | (10,474) | – | – | (21,108) | (31,582) |
Outstanding at | – | – | – | 230,605 | – | – | – | 319,017 | 549,622 |
Exercisable at | – | – | – | – | – | – | – | – | – |
Exercisable at | – | – | – | – | – | – | – | – | – |
Total | |||||||||
£m | £m | £m | £m | £m | £m | £m | £m | £m | |
Charge to income for the current year | – | – | – | 0.2 | – | – | – | 0.2 | 0.4 |
Charge to income for the prior year | – | – | – | 0.4 | – | – | – | – | 0.4 |
2023 | 2022 | |
Number of | Number of | |
Movements in the year | options | options |
Outstanding at beginning of the year | 5,726,376 | 4,804,517 |
Granted during the year | 4,082,706 | 2,631,126 |
Exercised during the year | (1,027,884) | (41,372) |
Lapsed during the year | (1,904,485) | (1,667,895) |
Outstanding at end of the year | 6,876,713 | 5,726,376 |
Exercisable at end of the year | 322,810 | 96,832 |
£m | £m | |
Charge to income for share incentive schemes | 1.5 | 1.9 |
Trade and other | Trade and other | |||||
receivables | Trade and other | receivables | Trade and other | |||
before | receivables | before | receivables | |||
expected | Expected | after expected | expected | Expected | after expected | |
credit loss | credit loss | credit loss | credit loss | credit loss | credit loss | |
2023 | 2023 | 2023 | 2022 | 2022 | 2022 | |
£m | £m | £m | £m | £m | £m | |
Non-current | ||||||
Trade receivables | 4.6 | (0.1) | 4.5 | 9.7 | – | 9.7 |
Due from joint ventures | 1.5 | – | 1.5 | 25.4 | (0.1) | 25.3 |
6.1 | (0.1) | 6.0 | 35.1 | (0.1) | 35.0 | |
Current | ||||||
Trade receivables | 57.1 | (0.7) | 56.4 | 49.7 | (0.3) | 49.4 |
Contract assets | 6.9 | – | 6.9 | 25.2 | (0.1) | 25.1 |
Due from joint ventures | 28.1 | (0.1) | 28.0 | 1.8 | – | 1.8 |
Other receivables | 27.0 | (0.2) | 26.8 | 38.1 | – | 38.1 |
Prepayments and accrued income | 1.9 | – | 1.9 | 1.9 | – | 1.9 |
121.0 | (1.0) | 120.0 | 116.7 | (0.4) | 116.3 | |
Non-current and current | 127.1 | (1.1) | 126.0 | 151.8 | (0.5) | 151.3 |
2023 | 2022 | |
£m | £m | |
Movements in total loss allowance for expected credit losses | ||
At beginning of the year | 0.5 | 12.3 |
Charged in the year on joint venture balances (note 14) | – | 2.3 |
Charged in the year on trade and other trade receivables | 0.7 | – |
Released in the year on contract assets | (0.1) | – |
Utilised in the year on joint venture balances (note 14) | – | (14.1) |
At end of the year | 1.1 | 0.5 |
2023 | 2022 | |
£m | £m | |
Maturity of non-current receivables: | ||
Due between one and two years | 5.8 | 34.2 |
Due between two and five years | 0.2 | 0.8 |
Due after five years | – | – |
6.0 | 35.0 |
2023 | 2022 | |
£m | £m | |
Work-in-progress | 1,040.7 | 942.8 |
Completed buildings including show homes | 89.6 | 30.1 |
Part exchange inventories | 34.5 | 17.2 |
1,164.8 | 990.1 |
2023 | 2022 | |
£m | £m | |
At beginning of the year | 12.6 | 20.7 |
Pre-exceptional NRV charged in the year | 13.4 | 9.6 |
Pre-exceptional NRV used in the year | (5.0) | (7.2) |
Exceptional NRV used in the year | (0.8) | (10.5) |
Total movement in NRV in the year | 7.6 | (8.1) |
At end of the year | 20.2 | 12.6 |
2023 | Movement | 2022 | |
£m | £m | £m | |
Cash and cash equivalents | 162.6 | (211.0) | 373.6 |
Bank loans and senior loan notes | (97.7) | (0.6) | (97.1) |
Net cash | 64.9 | (211.6) | 276.5 |
2023 | 2022 | |
£m | £m | |
Non-current | ||
Senior loan notes | 85.0 | 100.0 |
Revolving credit and senior loan notes issue costs | (1.5) | (2.9) |
83.5 | 9 7.1 | |
Current | ||
Senior loan notes | 15.0 | – |
Revolving credit and senior loan notes issue costs | (0.8) | – |
14.2 | – |
2023 | 2022 | |
£m | £m | |
Non-current | ||
Land payables on contractual terms | 64.7 | 32.9 |
Other payables | 2.0 | 2.3 |
Contract liabilities | 0.3 | 0.3 |
Accruals and deferred income | 4.1 | 6.3 |
71.1 | 41.8 | |
Current | ||
Land payables on contractual terms | 140.8 | 165.8 |
Other trade payables | 61.8 | 41.1 |
Contract liabilities | 5.7 | 19.0 |
Due to joint ventures | 0.7 | 0.1 |
Taxes and social security costs | 1.7 | 1.8 |
Other payables | 1.1 | 3.2 |
Accruals and deferred income | 125.2 | 176.1 |
337.0 | 407.1 |
Combustible | Other | ||||
materials | Legal provision | Joint ventures | provisions | Total | |
£m | £m | £m | £m | £m | |
At 1 November 2021 | 42.6 | – | – | 0.5 | 43.1 |
Provided in the year | 102.5 | – | – | 0.3 | 102.8 |
Imputed interest | 1.0 | – | – | – | 1.0 |
Utilised in the year | (5.3) | – | – | – | (5.3) |
Released in the year | – | – | – | (0.4) | (0.4) |
Funding commitment recognised | – | – | 1.2 | – | 1.2 |
Reclassification | – | – | – | 0.6 | 0.6 |
At 31 October 2022 | 140.8 | – | 1.2 | 1.0 | 143.0 |
Provided in the year | 12.0 | 13.0 | – | 0.4 | 25.4 |
Imputed interest | 4.6 | – | – | – | 4.6 |
Utilised in the year | (12.6) | – | – | (0.6) | (13.2) |
Released in the year | – | – | – | (0.2) | (0.2) |
Funding commitment change | – | – | (0.3) | – | (0.3) |
At 31 October 2023 | 144.8 | 13.0 | 0.9 | 0.6 | 159.3 |
At 31 October 2023 | |||||
Non-current | 73.6 | – | – | 0.2 | 73.8 |
Current | 71.2 | 13.0 | 0.9 | 0.4 | 85.5 |
144.8 | 13.0 | 0.9 | 0.6 | 159.3 | |
At 31 October 2022 | |||||
Non-current | 70.5 | – | – | 0.3 | 70.8 |
Current | 70.3 | – | 1.2 | 0.7 | 72.2 |
140.8 | – | 1.2 | 1.0 | 143.0 |
Shares issued | Nominal value | Share capital | Share premium | |
Number | Pence | £ | account | |
Ordinary shares as at 1 November 2021, 31 October 2022 | ||||
and 31 October 2023 | 256,920,539 | 5 | 12,846,027 | 74,227,216 |
Contractual | More than | |||||
Carrying value | cash flows | Within 1 year | 1-2 years | 2-3 years | ||
2023 | £m | £m | £m | £m | £m | £m |
Senior loan notes | 100.0 | 112.5 | 18.5 | 23.1 | 2.4 | 68.5 |
Financial liabilities carrying no interest | 401.4 | 408.8 | 333.5 | 44.1 | 28.3 | 2.9 |
At 31 October 2023 | 501.4 | 521.3 | 352.0 | 67.2 | 30.7 | 71.4 |
Contractual | More than | |||||
Carrying value | cash flows | Within 1 year | 1-2 years | 2-3 years | ||
2022 | £m | £m | £m | £m | £m | £m |
Senior loan notes | 100.0 | 116.1 | 3.5 | 18.5 | 23.1 | 71.0 |
Financial liabilities carrying interest | 29.8 | 30.1 | 30.1 | – | – | – |
Financial liabilities carrying no interest | 395.2 | 397.8 | 357.6 | 37.5 | 1.1 | 1.6 |
At 31 October 2022 | 525.0 | 544.0 | 391.2 | 56.0 | 24.2 | 72.6 |
2023 | 2022 | |
£m | £m | |
Sterling bank borrowings, loan notes and long-term creditors | ||
Financial liabilities carrying interest | 100.0 | 129.8 |
Financial liabilities carrying no interest | 401.4 | 395.2 |
501.4 | 525.0 |
2023 | 2022 | |
£m | £m | |
The maturity of the financial liabilities is: | ||
Repayable within one year | 344.0 | 385.2 |
Repayable between one and two years | 61.7 | 52.1 |
Repayable between two and five years | 78.9 | 72.1 |
Repayable after five years | 16.8 | 15.6 |
501.4 | 525.0 |
Nominal | Face value | Carrying value | Fair value | ||
interest rate | £m | £m | £m | Maturity | |
Current | |||||
Senior loan notes | 3.15% | 15.0 | 15.0 | 15.0 | 2024 |
Non-current | |||||
Senior loan notes | 3.32%–3.87% | 85.0 | 85.0 | 85.0 | 2025–2029 |
Total interest-bearing loans | 100.0 | 100.0 | 100.0 |
Nominal | Face value | Carrying value | Fair value | ||
interest rate | £m | £m | £m | Maturity | |
Senior loan notes | 3.15%–3.87% | 100.0 | 100.0 | 100.0 | 2024–2029 |
Total non-current interest-bearing loans | 100.0 | 100.0 | 100.0 |
2023 | 2022 | |
£m | £m | |
Sterling cash deposits | 162.6 | 373.6 |
Trade receivables | 60.9 | 59.1 |
Amounts due from joint ventures | 29.5 | 27.1 |
Other receivables | 22.7 | 29.6 |
Total financial assets at amortised cost | 275.7 | 489.4 |
Financial assets at fair value through profit and loss | 3.7 | 4.6 |
Total financial assets | 279.4 | 494.0 |
2023 | 2022 | |
£m | £m | |
Senior loan notes | 100.0 | 100.0 |
Land payables on contractual terms carrying interest | – | 29.8 |
Land payables on contractual terms carrying no interest | 205.5 | 168.9 |
Amounts due to joint ventures | 0.7 | 0.1 |
Lease liabilities | 6.4 | 3.9 |
Other trade payables | 61.8 | 41.1 |
Other payables | 3.1 | 5.5 |
Accruals | 123.9 | 175.7 |
Total financial liabilities at amortised cost | 501.4 | 525.0 |
2023 | 2022 | |
£m | £m | |
Cash and cash equivalents | 162.6 | 373.6 |
Non-current Interest-bearing loans and borrowings | (83.5) | (97.1) |
Current Interest-bearing loans and borrowings | (14.2) | – |
Net cash | 64.9 | 276.5 |
Land payables on contractual terms carrying interest | – | (29.8) |
Land payables on contractual terms carrying no interest | (205.5) | (168.9) |
Net cash and land creditors | (140.6) | 77.8 |
2023 | 2022 | |
£m | £m | |
Interest income on joint venture funding | 1.2 | 2.1 |
Project management fees recognised | 1.9 | 2.0 |
Amounts due from joint ventures, net of expected credit losses | 29.5 | 27.1 |
Amounts due to joint ventures | 0.7 | 0.1 |
Funding to joint ventures | (13.0) | (7.5) |
Repayment of funding from joint ventures | 11.7 | 18.8 |
Dividends received from joint ventures | 1.5 | 2.4 |
Voting | ||||
rights and | ||||
shareholding | ||||
Registered | Active/ | (direct or | ||
Entity name | dormant | Year end date | indirect) | |
Bath Riverside Estate Management Company Limited | 2 | Dormant | 31 October | 100% |
Bath Riverside Liberty Management Company Limited | 2 | Dormant | 31 October | 100% |
Castle Bidco Home Loans Limited | 1 | Active | 31 October | 100% |
Brightwells Residential 1 Company Limited | 1 | Dormant | 31 October | 100% |
Bristol Parkway North Limited | 1 | Dormant | 31 October | 100% |
Building 7 Harbourside Management Company Limited | 2 | Active | 31 December | 58.33% |
Buildings 3A, 3B & 4 Harbourside Management Company Limited | 2 | Dormant | 31 December | 83.33% |
Clevedon Developments Limited | 1 | Dormant | 31 October | 100% |
Clevedon Investment Limited | 1 | Active | 31 October | 100% |
CN Finance plc * | 1 | Active | 31 October | 100% |
CN Nominees Limited | 1 | Dormant | 31 October | 100% |
CN Properties Limited | 1 | Dormant | 31 October | 100% |
CN Secretarial Limited | 1 | Dormant | 31 October | 100% |
CN Shelf 2 LLP | 1 | Dormant | 31 October | 100% |
CN Shelf 3 LLP | 1 | Dormant | 31 October | 100% |
Crest (Claybury) Limited | 1 | Dormant | 31 October | 100% |
Crest Developments Limited | 1 | Dormant | 31 October | 100% |
Crest Estates Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Eastern) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Midlands) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Nominees) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Nominees No. 2) Limited | 1 | Active | 31 October | 100% |
Crest Homes (Northern) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (South East) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (South West) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (South) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Wessex) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Westerham) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes Limited | 1 | Dormant | 31 October | 100% |
Crest Manhattan Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Bath) Holdings Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Chiltern) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Eastern) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Epsom) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Henley-on-Thames) Limited | 1 | Active | 31 October | 100% |
Crest Nicholson (Highlands Farm) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Londinium) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Midlands) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Peckham) Limited | 1 | Active | 31 October | 100% |
Voting | ||||
rights and | ||||
shareholding | ||||
Registered | Active/ | (direct or | ||
Entity name | dormant | Year end date | indirect) | |
Crest Nicholson (South East) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (South West) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (South) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Stotfold) Limited | 1 | Active | 31 October | 100% |
Crest Nicholson Developments (Chertsey) Limited | 1 | Active | 31 October | 100% |
Crest Nicholson Operations Limited | 1 | Active | 31 October | 100% |
Crest Nicholson Pension Trustee Limited | 1 | Dormant | 31 January | 100% |
Crest Nicholson plc | 1 | Active | 31 October | 100% |
Crest Nicholson Projects Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Properties Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Regeneration Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential (London) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential (Midlands) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential (South East) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential (South) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Wheatley) LLP | 1 | Active | 31 October | 100% |
Crest Partnership Homes Limited | 1 | Dormant | 31 October | 100% |
Crest Strategic Projects Limited | 1 | Dormant | 31 October | 100% |
Eastern Perspective Management Company Limited | 1 | Dormant | 31 October | 100% |
Essex Brewery (Walthamstow) LLP | 1 | Dormant | 31 October | 100% |
Harbourside Leisure Management Company Limited | 1 | Active | 30 December | 71.43% |
Landscape Estates Limited | 1 | Dormant | 31 October | 100% |
Mertonplace Limited | 1 | Dormant | 31 October | 100% |
Nicholson Estates (Century House) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Central Plaza) Limited | 1 | Dormant | 31 October | 100% |
Ellis Mews (Park Central) Management Limited | 1 | Active | 31 October | 100% |
Park Central Management (Zone 11) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 12) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 1A North) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 1A South) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 1B) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 3/1) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 3/2) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 3/3) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 3/4) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 4/41 & 42) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 4/43/44) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 5/53) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 5/54) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 5/55) Limited | 1 | Dormant | 31 October | 100% |
Voting | ||||
rights and | ||||
shareholding | ||||
Registered | Active/ | (direct or | ||
Entity name | dormant | Year end date | indirect) | |
Park Central Management (Zone 6/61-64) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 7/9) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 8) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 9/91) Limited | 1 | Dormant | 31 January | 100% |
Park West Management Services Limited | 1 | Active | 29 March | 62.00% |
Voting | ||||
rights and | ||||
shareholding | ||||
Registered | Active/ | (direct or | ||
Entity name | dormant | Year end date | indirect) | |
Material joint ventures | ||||
Crest A2D (Walton Court) LLP | 1 | Active | 31 March | 50% |
Elmsbrook (Crest A2D) LLP | 4 | Active | 31 March | 50% |
Crest Sovereign (Brooklands) LLP | 3 | Active | 31 October | 50% |
Crest Peabody (Turweston) LLP | 1 | Active | 31 May | 50% |
Other joint ventures not material to the Group | ||||
Crest/Vistry (Epsom) LLP | 1 | Active | 31 October | 50% |
Crest Nicholson Bioregional Quintain LLP | 1 | Active | 31 October | 50% |
English Land Banking Company Limited | 1 | Active | 31 October | 50% |
Haydon Development Company Limited | 2 | Active | 30 April | 21.36% |
North Swindon Development Company Limited | 2 | Active | 31 December | 32.64% |